Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.17 - $765.0 $2,700 - $12.2 Million
15,883 Added 21.26%
90,582 $14,000
Q4 2021

Feb 08, 2022

SELL
$1.03 - $2.48 $35,298 - $84,989
-34,270 Reduced 31.45%
74,699 $78,000
Q3 2021

Nov 15, 2021

BUY
$2.14 - $4.95 $233,193 - $539,396
108,969 New
108,969 $247,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $116M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.